Actively Recruiting
Observational Study Evaluating Blood Biomarkers and Retinal Imaging to Predict Pregnancy Complications in First-Time Pregnant Women
Led by Medicines360 · Updated on 2026-09-30
5500
Participants Needed
2
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a multi-site, prospective, observational cohort study focusing on nulliparous women carrying a single fetus during pregnancy. The study aims to evaluate blood-based biomarkers and retinal imaging to predict pregnancy complications such as preeclampsia, fetal growth restriction, and gestational diabetes. This research is designed to improve risk evaluation and management of these conditions during pregnancy. Participants will not receive any treatment as this is an observational study. The research includes two parts one cohort focuses on developing and validating blood-based biomarkers at different gestational timepoints, while the other develops and validates a retinal imaging algorithm for predicting preeclampsia. These assessments occur from early pregnancy through approximately four weeks after delivery. During the study, participants will provide blood samples and undergo ocular imaging. Data on pregnancy outcomes and biospecimen samples will be collected and stored in a biobank. Researchers will analyze these data to identify risk cut-offs and validate biomarker accuracy. The total participation duration spans from enrollment in early pregnancy until about one month postpartum, with ongoing monitoring of pregnancy outcomes and retinal imaging results.
CONDITIONS
Brief Title
Advancing Stillbirth Prevention Through Innovative Risk Evaluation (ASPIRE) Clinical Study
Research Team
C
Carrie Fralick, MS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here